Knight Therapeutics Inc - Jun 11, 2025 Form 4 Insider Report for Synergy CHC Corp. (SYNR)

Role: 10%+ Owner
Signature: /s/ Samira Sakhia
Stock symbol: SYNR
Transactions as of: Jun 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/13/2025, 04:05 PM
Previous filing: Oct 22, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Knight Therapeutics Inc	10%+ Owner	3400 DE MAISONNEUVE W., SUITE 1055, MONTREAL, QUEBEC, CANADA	/s/ Samira Sakhia	2025-06-13	0001756235

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SYNR	Pre-Funded Common Stock Purchase Warrant	Purchase	$0	+429K		$0.00	429K	Jun 11, 2025	Common Stock	429K		See footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Pre-Funded Common Stock Purchase Warrants (the "Warrants") are exercisable by the holder at any time on or after June 11, 2025 at an exercise price equal to $0.00001 per share, subject to adjustments as provided under the terms of the Warrant, subject to a post-exercise beneficial ownership limitation of 19.90% ("Beneficial Ownership Limitation").
F2	The Warrants will expire on June 11, 2026 with automatic extensions of one year each in case the Warrants have not been exercised in full due to the Beneficial Ownership Limitation.
F3	The 428,570 Warrants are held by Knight Therapeutics International S.A. ("Knight Subsidiary"), a wholly-owned subsidiary of the Reporting Person. The Reporting Person is the sole owner of Knight Subsidiary and, as a result, may be deemed the beneficial owner for purposes of the U.S. Securities Exchange Act of 1934 ("Act") of any securities of Issuer beneficially owned by Knight Subsidiary. The Reporting Person disclaims beneficial ownership over all of the securities beneficially owned by Knight Subsidiary, other than for the purpose of determining obligations under the Act, and the filing of this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for any other purpose.